Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-265-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Justification for type of information:
- JUSTIFICATION FOR DATA WAIVING
The screening for reproductive / developmental toxicity required at REACH Annex VIII level has been waived based on the following elements:
1. An OECD 422 study (Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test) using Bisphenol AF (CAS 1478-61-1), the main constituent of the XA-31 reaction mass, is publicly available from Japanese Authorities (see details in attached justification). The study is summarized as follows:
“The oral administration of 4,4’-(1,1,1,3,3,3-Hexafluoropropane-2,2-diyl) diphenol [Bisphenol AF] to rats for a period of up to fifty-five days (including two weeks pre-mating, gestation and early lactation period for females) at dose levels of up to 300 mg/kg/day resulted in treatment-related changes at all dose levels.
For male animals, a ‘No Observed Adverse Effect Level’ (NOAEL) could not be established because of the microscopic changes in the mammary gland at all treatment levels, infertility at 300 mg/kg/day and reduced fertility at 100 and 30 mg/kg/day.
For female animals treated with 300 mg/kg/day, pregnancy was not achieved. For parental females, a NOAEL for systemic toxicity was achieved at 30 mg/kg/day because effects at 30 mg/kg/day were not considered to represent an adverse health effect for systemic toxicity. A NOAEL was not achieved for reproductive toxicity because of reduced pregnancy rates for parental females treated with 100 and 30 mg/kg/day compared to parental females from the control group.
For F1 offspring, the ‘No Observed Effect Level’ (NOEL) and NOAEL was 100 mg/kg/day under these test conditions.”
2. In the OECD 407 study (Repeated Dose 28-day Oral Toxicity Study in Rodents) on XA-31, histopathological findings were observed in the genital organs. Treatment-related atrophy of prostate, seminal vesicles and/or coagulating glands were seen in males at > 300 mg/kg/d. Potentially treatment related mild spermatid retention, minimal atrophy of Leydig cells and minimal tubular atrophy were seen in an isolated male given 1000 mg/kg/d. Also potentially treatment related feminization of mammary glands was observed at 1000 mg/kg/d. Given the design of the study and their nature and incidence, such findings are not sufficient for triggering classification, but are indicative of potential reproductive / developmental effects. Effects of the Bisphenol AF constituent on the testis in vivo are described in the scientific literature (see details in attached justification).
Together with animal welfare considerations and an effort in reducing testing in vertebrates, the performance of a screening for reproductive / developmental toxicity study at this tonnage level is not considered to be relevant.
Data source
Materials and methods
Results and discussion
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.